Company: CI
Filing Date: 2025-05-02
Form Type: 10-Q
Source: 0001739940-25-000021
Chunk: 16

Company: Cigna Group
Filing Date: 2025-05-02
Form: 10-Q
Item: Part I, Item 1
Chunk 16
---
Item 1. FINANCIAL STATEMENTS

The Cigna GroupConsolidated Statements of IncomeUnauditedThree Months Ended March 31,(In millions, except per share amounts)20252024RevenuesPharmacy revenues$48,633 $42,036 Premiums12,736 11,603 Fees and other revenues3,895 3,326 Net investment income238 290 TOTAL REVENUES65,502 57,255 Benefits and expensesPharmacy and other service costs48,398 41,431 Medical costs and other benefit expenses10,498 9,440 Selling, general and administrative expenses4,213 3,705 Amortization of acquired intangible assets422 423 TOTAL BENEFITS AND EXPENSES63,531 54,999 Income from operations1,971 2,256 Interest expense and other(362)(322)Gain (loss) on sale of businesses41 (19)Net investment losses(2)(1,836)Income before income taxes1,648 79 TOTAL INCOME TAXES239 291 Net income (loss)1,409 (212)Less: Net income attributable to noncontrolling interests86 65 SHAREHOLDERS' NET INCOME (LOSS)$1,323 $(277)Shareholders' net income (loss) per shareBasic$4.88 $(0.97)Diluted$4.85 $(0.97)

The accompanying Notes to the Consolidated Financial Statements (unaudited) are an integral part of these statements.

3

The Cigna GroupConsolidated Statements of Comprehensive IncomeUnauditedThree Months Ended March 31,(In millions)20252024Net income (loss)$1,409 $(212)Other comprehensive income (loss), net of taxNet unrealized (depreciation) appreciation on securities and derivatives(100)121 Net long-duration insurance and contractholder liabilities measurement adjustments(168)(560)Net translation gains (losses) on foreign currencies13 (26)Postretirement benefits liability adjustment6 5 Other comprehensive loss, net of tax(249)(460)Total comprehensive income (loss)1,160 (672)Less: Net income attributable to noncontrolling interests86 65 SHAREHOLDERS' COMPREHENSIVE INCOME (LOSS)$1,074 $(737)

The accompanying Notes to the Consolidated